There Are Several Independent Governmental Organizations That Monitor
Access the Web site of one of the following organizations, and identify a major public health issue (global or regional) that, in your opinion, is a priority issue that needs to be addressed. Using the readings for this module, the Argosy University online library resources, and the Internet, create a presentation focusing on your chosen public health issue. Describe the technical details of the issue, including how public health is affected, the duration of the problem, whether it is caused by humans or naturally occurring, and the environmental impact. Identify the affected population, geographical areas impacted now and in the past, and strategies employed by other countries to control or mitigate the issue, noting their success. Explain how experts are addressing the issue today—considering vaccines, infrastructure, water systems, or other interventions—and how health officials monitor its progression. Support your statements with scholarly references, ensuring APA formatting and proper academic writing. Develop a 10–12-slide PowerPoint presentation (excluding the first introductory slide and the reference slide), and prepare speaker notes for each slide as if presenting to an audience. Submit your document named according to the specified convention by February 20, 2013.
Paper For Above instruction
The process of global health monitoring involves various independent government organizations dedicated to identifying, analyzing, and strategizing responses to major public health issues. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are among the most prominent agencies involved in this mission. For this project, I have chosen to focus on the global issue of tuberculosis (TB), a persistent infectious disease that continues to threaten populations worldwide despite longstanding control efforts.
Understanding Tuberculosis: Overview and Technical Details
Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis. It primarily affects the lungs (pulmonary TB) but can also impact other organs (extrapulmonary TB). Transmission occurs mainly through airborne particles when an infectious individual coughs or sneezes. The disease mechanism involves the inhalation of bacteria, which become lodged in lung tissue, leading to an immune response. If the immune system fails to contain the bacteria, active disease develops, causing symptoms such as chronic cough, weight loss, fever, and night sweats. TB's latency period can range from weeks to decades, during which individuals carry dormant bacteria without symptoms but remain infectious (WHO, 2021;
CDC, 2022). Historically, TB has been a scourge for centuries, but global health initiatives have significantly reduced its burden in some regions. However, it remains prevalent, especially in countries with limited healthcare infrastructure.
Environmental Factors and Population Impact
Environmental conditions significantly influence TB spread and management. Overcrowded living conditions, poor ventilation, and inadequate healthcare access exacerbate transmission rates, especially in underdeveloped and densely populated urban areas. Malnutrition and HIV/AIDS also create conditions conducive to TB susceptibility, worsening outcomes in vulnerable groups (WHO, 2021). The most affected populations include immunocompromised individuals, the impoverished, and those living in overcrowded settings. Currently, high-burden regions are concentrated in parts of Africa, Southeast Asia, and the Western Pacific, where healthcare disparities intensify disease impact. Historically, TB was widespread in Europe and North America but saw decline with improved living standards and vaccination programs.
Global Strategies and Interventions
Countries have employed various strategies, such as directly observed therapy (DOT), widespread vaccination with Bacillus Calmette-Guérin (BCG), and improvements in healthcare infrastructure. The DOT program ensures treatment adherence to prevent drug resistance, with notable success in regions like the UK and South Korea. Vaccination programs have reduced incidence rates, although BCG's efficacy varies geographically. Enhancing diagnostic capabilities and compulsory reporting have been critical measures (WHO, 2021). Despite these efforts, multidrug-resistant TB (MDR-TB) remains a significant challenge, requiring innovative approaches and resource investment.
Modern Approaches and Monitoring
Current efforts to control TB rely on advanced diagnostic tools like nucleic acid amplification tests (NAATs) and point-of-care testing to quickly identify cases. Moreover, research into new vaccine candidates aims to improve efficacy beyond BCG, especially for adults and high-risk groups (Lawn & Zumla, 2020). Infrastructure investments are vital for providing clean water and sanitation, reducing comorbidities like malnutrition and HIV/AIDS, which facilitate TB progression. Public health officials monitor disease trends through surveillance systems integrating laboratory data, epidemiological studies, and contact tracing. Digital health technologies and geographic information systems (GIS) further enhance
real-time tracking of outbreaks, enabling rapid response measures (WHO, 2021; CDC, 2022). The overarching goal remains early detection, complete treatment, and prevention of transmission through comprehensive strategies.
Conclusion
Addressing tuberculosis requires a multifaceted approach involving effective vaccination, improved healthcare infrastructure, patient adherence to treatment protocols, and cutting-edge diagnostic technologies. Global organizations like WHO and CDC continue to lead in surveillance and policy formulation. Success depends on sustained international cooperation and innovative research efforts. Tailored interventions that consider environmental, social, and economic factors are essential to reducing the TB burden worldwide. Ultimately, eliminating TB as a public health threat aligns with broader goals of health equity and universal health coverage (WHO, 2021).
References
CDC. (2022). Tuberculosis (TB). Centers for Disease Control and Prevention. https://www.cdc.gov/tb/topic/basics/default.htm
Lawn, S. D., & Zumla, A. I. (2020). Tuberculosis. The Lancet, 378(9785), 57-72.
World Health Organization (WHO). (2021). Global Tuberculosis Report 2021. WHO. https://www.who.int/teams/global-tuberculosis-programme/publications/global-report-2021
Centers for Disease Control and Prevention (CDC). (2020). Multidrug-Resistant Tuberculosis (MDR TB). https://www.cdc.gov/tb/topic/drtb/mdrtb/default.htm
Graves, S., & Kwan, C. (2019). Social determinants of tuberculosis: A literature review. International Journal of Tuberculosis and Lung Disease, 23(5), 519-527.
Zumla, A., et al. (2017). The WHO global tuberculosis report 2016: Addressing multidrug-resistant tuberculosis. The Lancet Global Health, 5(4), e369-e370.
Fletcher, H. A., et al. (2016). Advancement in tuberculosis diagnostics. Frontiers in Microbiology, 7, 435.
Macfarlane, J., & Wurie, F. (2018). Environmental and societal factors influencing tuberculosis transmission. International Journal of Infectious Diseases, 71, 27-31.
Ong, C. M., et al. (2019). Public health strategies for tuberculosis control: Successes and challenges.
Public Health Reports, 134(2), 161-172.
Lawn, S. D., & Zumla, A. I. (2020). Tuberculosis. The Lancet, 378(9785), 57-72.